{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:20:38Z","timestamp":1751430038949,"version":"3.41.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cpet.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:03:17Z","timestamp":1749495797000},"page":"379-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate-Specific Membrane Antigen PET\/Computed Tomography"],"prefix":"10.1016","volume":"20","author":[{"given":"Larissa Bastos","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla Romano","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"de Galiza Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejrad.2015.10.012","article-title":"Diagnostic accuracy of imaging methods for the diagnosis of skeletal malignancies: A retrospective analysis against a pathology-proven reference","volume":"85","author":"Lange","year":"2016","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.biopha.2012.06.004","article-title":"Early bone marrow metastasis detection: the additional value of FDG-PET\/CT vs. CT imaging","volume":"66","author":"Evangelista","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","article-title":"68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging","volume":"23","author":"Eder","year":"2012","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib5","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1148\/rg.2020200058","article-title":"Prostate-specific Membrane Antigen PET: Therapy Response Assessment in Metastatic Prostate Cancer","volume":"40","author":"Barbosa","year":"2020","journal-title":"Radiographics"},{"issue":"7","key":"10.1016\/j.cpet.2025.04.004_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","article-title":"A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies","volume":"59","author":"O\u2019Keefe","year":"2018","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.93.2.749","article-title":"Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase","volume":"93","author":"Carter","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.cpet.2025.04.004_bib8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","article-title":"Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer","volume":"43","author":"Pfob","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.semnuclmed.2019.02.004","article-title":"Molecular Imaging for Primary Staging of Prostate Cancer","volume":"49","author":"Pomykala","year":"2019","journal-title":"Semin Nucl Med"},{"year":"2016","series-title":"PET-based molecular imaging in evolving personalized management design, an issue of PET clinics (The Clinics: Internal Medicine Book 11)","author":"Basu","key":"10.1016\/j.cpet.2025.04.004_bib10"},{"key":"10.1016\/j.cpet.2025.04.004_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apradiso.2012.06.034","article-title":"Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography","volume":"76","author":"Sanchez-Crespo","year":"2013","journal-title":"Appl Radiat Isot"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.semnuclmed.2019.02.006","article-title":"Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls","volume":"49","author":"Sheikhbahaei","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.semnuclmed.2019.02.001","article-title":"New Targets for PET Molecular Imaging of Prostate Cancer","volume":"49","author":"Mena","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2025.04.004_bib14","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1091\/mbc.e02-11-0731","article-title":"A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen","volume":"14","author":"Rajasekaran","year":"2003","journal-title":"Mol Biol Cell"},{"issue":"18","key":"10.1016\/j.cpet.2025.04.004_bib15","first-page":"4055","article-title":"Constitutive and antibody-induced internalization of prostate-specific membrane antigen","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib16","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of Hybrid 68Ga-PSMA Ligand PET\/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1148\/rg.2019180079","article-title":"Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of Spread","volume":"39","author":"Barbosa","year":"2019","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-016-3578-z","article-title":"Early dynamic imaging in Ga- PSMA-11 PET\/CT allows discrimination of urinary bladder activity and prostate cancer lesions","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib21","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/RLU.0000000000002354","article-title":"Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET\/CT for Prostate Cancer","volume":"44","author":"Panagiotidis","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2025.04.004_bib22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2967\/jnumed.117.204677","article-title":"Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging","volume":"59","author":"Rischpler","year":"2018","journal-title":"J Nucl Med"},{"year":"2023","series-title":"Renal cancer: old and new paradigms, an issue of urologic clinics: Volume 50-2, 1st Edition. E-Book","author":"Blute","key":"10.1016\/j.cpet.2025.04.004_bib23"},{"issue":"12","key":"10.1016\/j.cpet.2025.04.004_bib24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2967\/jnumed.117.190215","article-title":"Detection of Synchronous Primary Malignancies with Ga-Labeled Prostate-Specific Membrane Antigen PET\/CT in Patients with Prostate Cancer: Frequency in 764 Patients","volume":"58","author":"Osman","year":"2017","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/radiol.2018181278","article-title":"A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI","volume":"290","author":"Mehralivand","year":"2019","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2967\/jnumed.121.262398","volume":"63","author":"Sonni","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14828","article-title":"Risk of metastatic disease on 68 gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer","volume":"124","author":"Yaxley","year":"2019","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.cpet.2025.04.004_bib28","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00259-022-05756-2","article-title":"Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy","volume":"49","author":"Roberts","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10231","key":"10.1016\/j.cpet.2025.04.004_bib29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN Guidelines Insights: Prostate Cancer, Version 1.2021","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bju.13540","article-title":"Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer","volume":"119","author":"van Leeuwen","year":"2017","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.euo.2020.06.012","volume":"4","author":"Anttinen","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib35","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.2214\/AJR.14.13280","article-title":"Prostate cancer: top places where tumors hide on multiparametric MRI","volume":"204","author":"Rosenkrantz","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","article-title":"68Ga-PSMA Positron Emission Tomography\/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study","volume":"200","author":"Lopci","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.juro.2018.01.002","article-title":"Clinically Localized Prostate Cancer: AUA\/ASTRO\/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"issue":"34","key":"10.1016\/j.cpet.2025.04.004_bib38","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2014.58.8525","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement","volume":"32","author":"Freedland","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2312030011","article-title":"Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging","volume":"231","author":"Sella","year":"2004","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib40","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-3919.198450","article-title":"Rare Sites of Metastases in Prostate Cancer Detected on Ga-68 PSMA PET\/CT Scan-A Case Series","volume":"32","author":"Dureja","year":"2017","journal-title":"Indian J Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib42","doi-asserted-by":"crossref","first-page":"e233522","DOI":"10.1136\/bcr-2019-233522","article-title":"PSMA-PET\/CT-avid metastatic prostate cancer to the penis","volume":"13","author":"Mary Mansbridge","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PAS.0000000000000289","article-title":"Metastatic prostate adenocarcinoma to the penis: a series of 29 cases with predilection for ductal adenocarcinoma","volume":"39","author":"Ellis","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1308\/003588403322520726","article-title":"Rectal infiltration by prostatic adenocarcinoma: report on six patients and review of the literature","volume":"85","author":"Bowrey","year":"2003","journal-title":"Ann R Coll Surg Engl"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2016.11.023","article-title":"Delineating biochemical failure with Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer","volume":"122","author":"Hruby","year":"2017","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2025.04.004_bib46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2967\/jnumed.116.184457","article-title":"Detection Efficacy of Hybrid Ga-PSMA Ligand PET\/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria","volume":"58","author":"Einspieler","year":"2017","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brachy.2014.11.008","article-title":"Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy","volume":"14","author":"Raleigh","year":"2015","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"H\u00f6vels","year":"2008","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3322\/caac.21391","article-title":"Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Buyyounouski","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12894-016-0173-3","article-title":"Cancer-specific and overall survival in patients with recurrent prostate cancer who underwent salvage extended pelvic lymph node dissection","volume":"16","author":"Osmonov","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.cpet.2025.04.004_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/321619","article-title":"Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer. Extended Salvage Pelvic Lymph Nodes Dissection in Patients with Recurrent Prostate Cance","author":"Osmonov","year":"2014","journal-title":"Adv Urol"},{"issue":"8","key":"10.1016\/j.cpet.2025.04.004_bib53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pros.23168","article-title":"See the unseen: Mesorectal lymph node metastases in prostate cancer","volume":"76","author":"Hijazi","year":"2016","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13244-011-0089-0","article-title":"Common primary tumours of the abdomen and pelvis and their patterns of tumour spread as seen on multi-detector computed tomography","volume":"2","author":"Griffin","year":"2011","journal-title":"Insights Imaging"},{"issue":"17","key":"10.1016\/j.cpet.2025.04.004_bib55","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib56","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eururo.2006.10.045","article-title":"The natural history of noncastrate metastatic prostate cancer after radical prostatectomy","volume":"51","author":"Yossepowitch","year":"2007","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.cpet.2025.04.004_bib57","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/1097-0142(19841215)54:12<3078::AID-CNCR2820541245>3.0.CO;2-U","article-title":"Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved","volume":"54","author":"Saitoh","year":"1984","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: A population-based analysis","volume":"74","author":"Gandaglia","year":"2014","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11307-017-1101-y","article-title":"[Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients","volume":"19","author":"Janssen","year":"2017","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/RLU.0000000000001582","article-title":"Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer","volume":"42","author":"Gro\u00dfe Hokamp","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib61","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RLU.0000000000000709","article-title":"Detection of brain metastasis with 68Ga-labeled PSMA ligand PET\/CT: a novel radiotracer for imaging of prostate carcinoma","volume":"40","author":"Chakraborty","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2025.04.004_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RLU.0000000000001526","article-title":"Cerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET\/CT","volume":"42","author":"Chan","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2025.04.004_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/RLU.0000000000001659","article-title":"Early Detection of Bilateral Testicular Metastases From Prostatic Adenocarcinoma Using 68Ga-PSMA Ligand PET\/CT","volume":"42","author":"Weiberg","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2025.04.004_bib64","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/RLU.0000000000001302","article-title":"Epididymal Metastasis of Prostate Cancer Detected With 68Ga-PSMA-PET\/CT","volume":"41","author":"Serfling","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrurol.2016.175","article-title":"Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations","volume":"14","author":"Tosoian","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib66","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.cpet.2025.04.004_bib67","article-title":"What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer","volume":"57","author":"Ballas","year":"2016","journal-title":"J Nucl Med"},{"issue":"13","key":"10.1016\/j.cpet.2025.04.004_bib68","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40644-016-0072-6","article-title":"68)Ga-PSMA ligand PET\/CT in patients with prostate cancer: How we review and report","volume":"16","author":"Rauscher","year":"2016","journal-title":"Cancer Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib70","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0022-5347(05)68241-9","article-title":"Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo","volume":"162","author":"Burchardt","year":"1999","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.118.219352","article-title":"Dosimetry of Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes","volume":"60","author":"Violet","year":"2019","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2025.04.004_bib72","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1007\/s00259-019-04485-3","article-title":"EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)","volume":"46","author":"Kratochwil","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2025.04.004_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib74","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2025.04.004_bib75","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2967\/jnumed.119.233817","article-title":"Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET\/CT Imaging: The PSMA PET Progression Criteria","volume":"61","author":"Fanti","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.04.004_bib76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0","volume":"280","author":"O","year":"2016","journal-title":"Radiology"},{"issue":"23","key":"10.1016\/j.cpet.2025.04.004_bib77","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1073\/pnas.1106383108","article-title":"Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen","volume":"108","author":"Evans","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cpet.2025.04.004_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-015-0145-8","article-title":"Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy","volume":"5","author":"Meller","year":"2015","journal-title":"EJNMMI Res"},{"issue":"7","key":"10.1016\/j.cpet.2025.04.004_bib79","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2967\/jnumed.118.223099","article-title":"Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade","volume":"60","author":"Emmett","year":"2019","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2025.04.004_bib80","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00259-018-4079-z","article-title":"Impact of long-term androgen deprivation therapy on PSMA ligand PET\/CT in patients with castration-sensitive prostate cancer","volume":"45","author":"Afshar-Oromieh","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2025.04.004_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.semnuclmed.2019.02.005","article-title":"Molecular Imaging of Recurrent and Metastatic Prostate Cancer","volume":"49","author":"Ware","year":"2019","journal-title":"Semin Nucl Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685982500032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685982500032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:10:51Z","timestamp":1751397051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155685982500032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S155685982500032X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2025.04.004","relation":{},"ISSN":["1556-8598"],"issn-type":[{"type":"print","value":"1556-8598"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate-Specific Membrane Antigen PET\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}